Global Autoimmune Disease Diagnostics Market (By Disease, Test Types, Country Analysis), Key Company Profiles, Strategy, Financial Insights, Recent Developments - Forecast To 2032
The global autoimmune disease diagnostics market was valued at US$ 5.90 Billion in 2023, and the market is predicted to reach US$ 11.63 Billion by 2032. There are over 80 types of autoimmune diseases prevailing worldwide of which multiple sclerosis, type 1 diabetes, and rheumatoid arthritis are most common. As per the American Autoimmune Related Diseases Association, around 50 million Americans currently suffer from autoimmune related disorders.
Global Drug Of Abuse Testing Market (By Product Type, Sample Type, Drug Type, End Users, Country Analysis), Regulatory Status, Recent Developments, Company Profiles - Forecast To 2032
The global drug of abuse testing market was valued at US$ 6,973 Million in 2023, and is predicted to reach US$ 11,715 Million by 2032. The cannabis/marijuana segment dominated the global drug of abuse testing market, backed by growth in the production and consumption of marijuana across the globe. There are currently over 228 million cannabis users worldwide.
Global Food Safety Testing Market (by Contaminants, Pathogens, Types Of Food Tested, Technology, Regional Analysis), Company Profiles, Major Acquisitions, Trends And Recent Developments - Forecast To 2032
The global food safety testing market is predicted to increase from US$ 22.02 Billion in 2023 to around US$ 40.82 Billion by 2032. Based on food type, the global food safety testing market is dominated by Meat and poultry, followed by Processed food products, as maximum number of illnesses have been associated with these applications globally. These two segments together accounted for around 59% share of the total food safety testing market in 2023.
Global Radiotherapy Market (By Technology, Procedure, Application, End User, Country Analysis), Company Profiles, Market Dynamics, Trends & Recent Developments - Forecast To 2030
The global radiotherapy market was valued at US$ 6.67 Billion in 2023, and is predicted to reach US$ 10.27 Billion by 2030. The primary goal of radiotherapy is to eradicate cancer cells while minimizing damage to surrounding tissues. More than 50% of cancer patients require radiotherapy as part of cancer care and it is frequently used to treat the most common types, such as breast, cervical, colorectal, and lung cancer.
Global Wound Care Market (by Product Type, Application, Wound Type, Country And Company Analysis), Size, Share, Acquisitions, Recent Developments - Forecast To 2032
The global wound care market was valued at US$ 23.1 Billion in 2023, and the market is predicted to reach US$ 35.2 Billion by 2032. The wound care industry has continued to expand with the continuous arrival of new and technologically advanced products. The advancements in wound care technologies, including smart dressings, bioengineered tissues, and digital wound monitoring, offer more sophisticated and effective solutions for wound management.
Global Electrotherapy System Market (By Technology, Therapy, Application, End User, Region), Key Company Profiles, SWOT Analysis, Trends And Recent Developments - Forecast To 2030
The global electrotherapy system market was valued at US$ 1,153.9 Million in 2023, and the market is poised to reach US$ 1,656.4 Million by 2030. The continuous technological advancements have led to the development of more sophisticated and user-friendly electrotherapy devices. These innovations make electrotherapy systems more accessible to both healthcare providers and patients, which helps in market expansion.
Global Point Of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Trends, Recent Developments, Company Profiles - Forecast To 2031
The global point of care testing (POCT) market is predicted to reach US$ 79.30 Billion by 2031, from US$ 44.24 Billion in 2023. Manufacturers in the POCT market are focusing on developing novel technologies for maximum testing within a minimum period. For instance, in February 2024, Abbott Laboratories secured regulatory approval from the FDA for its Binx Now COVID-19 & Flu A/B test. This point-of-care test has the capability to concurrently identify COVID-19, influenza A, and influenza B viruses.
Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End Users, Clinical Application, Cancer Types, Sample Type, Region & Country Analysis), Funding, Major Deals, Company Profiles And Recent Developments - Forecast To 2031
The global liquid biopsy market is predicted to reach US$ 13.72 Billion by 2031, from US$ 3.94 Billion in 2023. The advantages of liquid biopsy over solid tumor biopsy, rising prevalence of cancer, increasing preference for non-invasive procedures, growing public and private funding to support research activities in the field of liquid biopsy and favorable government initiatives, are some of the factors expected to propel market growth over the forecast period.
United States Liquid Biopsy Market (by Circulating Biomarker, Product, Application, Cancer Types, End User, Clinical Application, Sample Type), Initiatives, Funding, Major Deals, Company Profiles, And Recent Developments - Forecast To 2031
The United States liquid biopsy market was valued at around US$ 1,200 Million in 2023, and the market is projected to reach US$ 3,807 Million by 2031. The liquid biopsy market is a rapidly growing sector with numerous companies focusing on scientific advancements. For instance, in November 2023, Illumina Inc. announced TruSight Oncology 500 ctDNA v2, an advanced iteration of its liquid biopsy assay designed for comprehensive genomic profiling in oncology.
Global Neonatal Intensive Care Market (By Product Type, Application, End User And Region), Key Company Profiles, Trends, SWOT Analysis, And Recent Developments - Forecast To 2030
The global neonatal intensive care market is predicted to reach US$ 4.93 Billion by 2030, from US$ 3.45 Billion in 2023. The factors such as the rising incidence of preterm births, increasing prevalence of chronic diseases among newborn babies, and technological advancements in neonatal intensive care devices are likely to propel market growth over the forecast period. For instance, in 2022, there were 380,548 preterm births in the United States, representing 10.4% of live births.
Global Bionic Devices Market (By Product, Fixation, Technology, End User And Region), Key Company Profiles, Trends, SWOT Analysis, And Recent Developments - Forecast To 2030
The global bionic devices market was valued at US$ 5.76 Billion in 2023, and is projected to reach US$ 10.29 Billion by 2030. According to the WHO, over 430 million people have debilitating hearing loss, and almost 1.5 billion people have some sort of hearing impairment. The use of assistive devices such as cochlear implants has become critical in assisting persons with hearing loss, thereby driving the market growth.
 Market and Forecast to 2030.JPG)
China In-Vitro Diagnostics Market (By Segment, Company), Size, Share, Regulations, Reimbursement, Major Deals, Trends, Key Company Profiles, Sales Analysis, And Recent Developments - Forecast To 2030
China in-vitro diagnostics market is predicted to reach US$ 28.13 Billion by 2030, from US$ 11.96 Billion in 2023. China is the largest in-vitro diagnostics market in the Asia-Pacific region, and only second to the United States in terms of value. Immunoassay and Clinical Chemistry are the leading segments of the China IVD market. Together they contributed around 60 percent to the total China IVD market in 2023.
 Market and Forecast to 2030.JPG)
Saudi Arabia In-Vitro Diagnostics Market (By Technology, Application, Product, End User), Size, Share, Major Deals, Government Initiatives, Key Company Profiles, Revenue, Recent Developments - Forecast To 2030
Saudi Arabia in-vitro diagnostics market is predicted to reach US$ 1,195 Million by 2030, from US$ 780 Million in 2023. Saudi Arabian government is taking number of initiatives to improve the healthcare sector in the country. For instance, Under Vision 2030, the Saudi Arabian Government plans to invest over US$ 65 Billion to develop the country’s healthcare infrastructure. The government has set the target of privatizing 290 hospitals and 2,300 primary health centers by 2030.
 Market and Forecast to 2030.JPG)
Japan In-Vitro Diagnostics Market (by Segment And Company), Size, Share, Major Deals, Trends, Company Analysis And Recent Developments - Forecast To 2030
Japan in-vitro diagnostics market is predicted to reach US$ 6.62 Billion by 2030, from US$ 4.59 Billion in 2023. Japan is facing the challenges of fighting with infectious disease including HBV, TB, HCV, and HIV, as well as various chronic disease and cancer. Japan’s quickly aging population leads to an explosion of chronic conditions such as heart disease and cancer. All of these conditions can be diagnosed and monitored using IVD products.
 Market and Forecast to 2030.JPG)
South Korea In-Vitro Diagnostics Market (By Technology, Application, Product, End User), Size, Share, Major Deals, Government Initiatives, Key Company Profiles, Revenue, Recent Developments - Forecast To 2030
South Korea in-vitro diagnostics market is projected to reach US$ 5,014 Million by 2030, from US$ 3,466 Million in 2023. South Korean government is taking number of initiatives to improve the healthcare sector in the country. For instance, The Korean ‘Act on In Vitro Diagnostic Medical Devices’ came into effect on May 1, 2020, presenting an independent legal foundation to reinforce the IVD industry by promoting advanced technology to be applied promptly.